Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2005-04-05
2005-04-05
Leary, Louise N. (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S006120, C435S440000, C435S441000
Reexamination Certificate
active
06875582
ABSTRACT:
The present invention provides for a method of evolving and selecting cells resistant to a selective agent by inducing directed evolution in continuous culture while applying both a mutagenic and selective agent to the cells to determine the cells having resistance. This also provides a method of generating mutant drug targets useful for screening for effective compounds. The Figure is ageneralized schematic diagram of a chemostat of the present invention
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schurrs et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schurrs et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4528773 (1985-07-01), Hickok
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4736866 (1988-04-01), Leder et al.
patent: 4801531 (1989-01-01), Frossard
patent: 4879219 (1989-11-01), Wands et al.
patent: 5011771 (1991-04-01), Bellet et al.
patent: 5175383 (1992-12-01), Leder et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5192659 (1993-03-01), Simons
patent: 5221778 (1993-06-01), Byrne et al.
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5281521 (1994-01-01), Trojanowski et al.
patent: 5288846 (1994-02-01), Quertermous et al.
patent: 5298422 (1994-03-01), Schwartz et al.
patent: 5347075 (1994-09-01), Sorge
patent: 5360735 (1994-11-01), Weinshank et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5652098 (1997-07-01), Freyer
patent: 6720142 (2004-04-01), Hall
patent: WO93/14200 (1993-07-01), None
patent: WO94/06908 (1994-03-01), None
patent: WO9423049 (1994-10-01), None
patent: WO94/28123 (1994-12-01), None
patent: WO 01012842 (2001-02-01), None
Osuna et al, Protein engineering, V. 15(6), pp. 463-70, (Jun. 2002) (Abstract Only).*
Ausubel et al., “Current Protocols in Molecular Biology,”John Wiley&Sons(1989).
Birren et al., “Genome Analysis: A Laboratory Manual Series,” vols. 1-4,Cold Spring Harbor Lab Press(1998).
Borrebaeck, “Antibody Engineering—A Practical Guide.”.
Burke and Olson, “Preparation of Clone Libraries in Yeast Artifical-Chromosome Vectors” inMethods in Enzymology, vol. 194, “Guide to Yeast Genetics and MOlecular Biology,” eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 17, 251-270 (1991).
Capecchi, “Altering the genome by homologous recombination,”Science, 244:1288-1292 (1989).
Cregg JM, Vedvick TS, Raschke WC “Recent Advances in the Expression of Foreign Genes inPichia pastoris,” Bio/Technology, 11:905-910 (1993).
Davies et al., “Targeted alterations in yeast artifical chromsomes for inter-species gene transfer,”Nucleic Acids Research, 20(11):2693-2698 (1992).
Dickinson et al., “High frequency gene targeting using insertional vectors,”Human Molecular Genetics, 2(8):1299-1302 (1993).
Duff and Lincoln, “Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human APP gene and expression in ES cells,”Research Advances in Alzheimer's Disease and Related Disorders(1995).
Gilboa, E, Eglitis, MA, Kantoff, PW, Anderson, WF, “Transfer and expression of clones genes using retroviral vectors,”BioTechniques4(6):504-512 (1986).
Harlow and Lane, “Antibodies: A Laboratory Manual,”Cold Spring Harbor Laboratory(1988).
Huston et al., “Protein engineering of single-chain Fv analogs and fusion proteins,” inMethods in Enzymology(JJ Langone, ed.; Academic Press, New York, NY) 203:46-88 (1991).
Huxley et al., “The human HPRT gene of a yeast artificial chromosome is functional when transferred to mouse cells by cell fusion,”Genomics, 9:742-750 (1991).
Jakobovits et al., “Germ-line transmission and expression of a human-derived yeast artifical chromsome,”Nature, 362:255-261 (1993).
Johnson and Bird, “Construction of single-chain Fvb derivatives of monoclonal antibodies and their production inEscherichia coli,” inMethods in Enzymology(JJ Langon, ed.; Academic Press, New York, NY) 203:88-99 (1991).
Lamb et al., “Introduction and expression of the 400 kilobas precursor amyloid protein gene in transgenic mice,”Nature Genetics, 5:22-29 (1993).
Marshak et al., “Strategies for Protein Purification and Characterization,”A Laboratory Course Manual(1996).
Mernaugh and Mernaugh, “An overview of phage-displayed recombinant antibodies” inMolecular Methods In Plant Pathology(RP Singh and US Singh, eds., CRC Press Inc., Boca Raton, FL), 359-365 (1995).
Mishell and Shiigi, “Selected Methods in Cellular Immunology,”W.H. Freeman&Co.(1980).
PCR Protocols “A Guide to methods and Applications,”Academic Press(1990).
Pearson and Choi, “Expression of the human b-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice,”Proc. Natl. Acad. Sci. USA, 90:10578-82 (1993).
Rothstein, “Targeting, disruption, replacement, and allele rescue: integrative DNA transformation in yeast” inMethods in Enzymology, “Guide to Yeast Genetics and Molecular Biology,” eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 19, 194:281-301 (1991).
Sambrook et al., “Molecular Cloning: A Laboratory Manual,”Cold Spring Harbor Lab Press(1989).
Schedl et al., “A yeast artifical chromsome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice,”Nature, 362:258-261 (1993).
Stites et al., “Basic and Clinical Immunology,”Appletion&Lange, 8thEd. (1994).
Strauss et al., “Germ line transmission of a yeast artifical chromosome spanning the murine a1(I) collagen locus,”Science, 259:1904-1907 (1993).
Bertino, Joseph, et al., Drug resistant cells as targets for new therapies, Leukemia: Recent Advances in Biology and Treatment, pp. 529-536, Alan R. Liss, Inc. (1985).
Dykhuizen, Daniel, Chemostates used for studying natural selection and adaptive evolution, Methods in Enzymology, vol. 224, Academic Press, Inc. (1993).
Ferrero, Lucy, et al., Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of staphylococcus aureas, Antimicrobial Agents and Chemotherapy, Jul. 1995, p. 1554-1558.
Kolterman, et al., Principles and methods of evolutionary biotechnology, Biophysical Chemistry 66:159-177 Elsevier Science B.V. (1997).
Wiebe, Marilyn, et al., Use of a series of chemostate cultures to isolate “improved” variants of the Quorn mycoprotein fungus, Fusarium graminearum A3/5, Miccrobiology (1994) 140:3015-3021.
Wiebe et al; Microbiology, V. 140; pp. 3015-30-21; (1994). □□.
Bertino et al; Recent Advances in Biology and Treatment; pp. 529-536; (1985).
Azad Abul
Chaparian Michael G.
Kohn & Associates PLLC
Leary Louise N.
OmniScience Pharmaceuticals, Inc.
LandOfFree
Methods and targets of antibiotic resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and targets of antibiotic resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and targets of antibiotic resistance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3429925